Literature DB >> 6112422

Neurological dysfunction associated with abnormal levels of cimetidine metabolite.

J Totte, S Scharpe, R Verkerk, H Neels, M Vanhaeverbeek, S Smitz, J J Rousseau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6112422     DOI： 10.1016/s0140-6736(81)92203-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Switching drug availability from prescription only to over-the-counter status. Are elderly patients at increased risk?

Authors:  S I Benrimoj; J H Langford; M G Bowden; E J Triggs
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

Review 2.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

3.  Potentially lethal interaction of cimetidine and morphine.

Authors: 
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

4.  Histamine and Seizures : Implications for the Treatment of Epilepsy.

Authors:  H Yokoyama; K Iinuma
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

5.  Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure.

Authors:  C W Howden; C D Payton; P A Meredith; D M Hughes; A I Macdougall; J L Reid; J A Forrest
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.